Physicians’ business associates can now face civil and criminal penalties for violating HIPAA laws guarding the confidentiality of protected health information
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!
Pain Treatment Will to Become More Targeted as Knowledge of Pain Mechanics Increases
The notion of pain as just a peripheral, or strictly stimulus-driven, phenomenon is over.
ACR/ARHP Annual Meeting 2012: Genes Not the Only Factor in Susceptibility to Rheumatoid Arthritis
Epigenetics, innate immunity, and environmental stresses such as smoking could have more influence than scientists once believed
Rheuminations: Epigenetics May Help to Explain Why Some Get Rheumatic Disease
Recent research around genes and environmental stresses suggests outside influences can make lasting changes to the genome via epigenetic mechanisms
Why Universal Access to Healthcare Isn’t a Constitutional Right, It’s Just Plain Fair
One rheumatologist forms his opinion on the topic while fly fishing on rivers in Missouri
Blue Ribbon Panel on Academic Rheumatology Publishes Final Report
Report offers recommendations to address critical issues with training, practice, and research
Research into Methotrexate Could Lead to Improved Treatments for Rheumatoid Arthritis
With a grant from the ACR’s Rheumatology Research Foundation, Nancy J. Olsen, MD, hopes to discover how methotrexate interacts with immune system cells and ultimately helps to control the system’s attack on joints
ACR Advances Legislation to Increase Patients’ Access to Biologic Drugs to Treat Rheumatoid Arthritis and Other Conditions
The Patients’ Access to Treatments Act of 2013 would prevent insurance companies from tacking on an additional cost-sharing fee for the specialty medications
Five Quick Ways To Make a Difference in Rheumatology Through Advocacy
The ACR’s online advocacy page has position statements and work plans on issues affecting rheumatology, and offers ways to get involved
ACR/ARHP Annual Meeting 2012: Federal Act Aims to Make New Biologic Drugs Available to Rheumatology Patients at a Lower Cost
The Biologics Price Competition and Innovation Act of 2009 would spur the development of products intended to be biosimilar to approved therapies
- « Previous Page
- 1
- …
- 242
- 243
- 244
- 245
- 246
- …
- 307
- Next Page »